|
HY-110374-1mg
|
MedChemexpress LLC
|
NVS-CECR2-1 [CAS 1992047-61-6]
|
|
Cancer-programmed cell death
|
|
|
HY-110374-10mg
|
MedChemexpress LLC
|
NVS-CECR2-1 [CAS 1992047-61-6]
|
|
Cancer-programmed cell death
|
|
|
HY-110374-100mg
|
MedChemexpress LLC
|
NVS-CECR2-1 [CAS 1992047-61-6]
|
|
Cancer-programmed cell death
|
|
|
HY-110374-25mg
|
MedChemexpress LLC
|
NVS-CECR2-1 [CAS 1992047-61-6]
|
|
Cancer-programmed cell death
|
|
|
HY-110374-5mg
|
MedChemexpress LLC
|
NVS-CECR2-1 [CAS 1992047-61-6]
|
|
Cancer-programmed cell death
|
|
|
HY-110374-50mg
|
MedChemexpress LLC
|
NVS-CECR2-1 [CAS 1992047-61-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108608-10mg
|
MedChemexpress LLC
|
o-3M3FBS [CAS 313981-55-4]
|
|
|
|
|
HY-108608-25mg
|
MedChemexpress LLC
|
o-3M3FBS [CAS 313981-55-4]
|
|
|
|
|
HY-108608-5mg
|
MedChemexpress LLC
|
o-3M3FBS [CAS 313981-55-4]
|
|
|
|
|
HY-108608-50mg
|
MedChemexpress LLC
|
o-3M3FBS [CAS 313981-55-4]
|
|
|
|
|
HY-18676-10mg
|
MedChemexpress LLC
|
OSU-T315 [CAS 2070015-22-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-18676-5mg
|
MedChemexpress LLC
|
OSU-T315 [CAS 2070015-22-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-18676-50mg
|
MedChemexpress LLC
|
OSU-T315 [CAS 2070015-22-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-18676-1mL
|
MedChemexpress LLC
|
OSU-T315 [CAS 2070015-22-2] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-101372A-10mg
|
MedChemexpress LLC
|
Oxotremorine M (iodide) [CAS 3854-04-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-101372A-100mg
|
MedChemexpress LLC
|
Oxotremorine M (iodide) [CAS 3854-04-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-101372A-5mg
|
MedChemexpress LLC
|
Oxotremorine M (iodide) [CAS 3854-04-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-101372A-50mg
|
MedChemexpress LLC
|
Oxotremorine M (iodide) [CAS 3854-04-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-101372A-1mL
|
MedChemexpress LLC
|
Oxotremorine M (iodide) [CAS 3854-04-4] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-B0267A-100mg
|
MedChemexpress LLC
|
Oxybutynin (chloride) [CAS 1508-65-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-B0267A-500mg
|
MedChemexpress LLC
|
Oxybutynin (chloride) [CAS 1508-65-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-B0267A-1mL
|
MedChemexpress LLC
|
Oxybutynin (chloride) [CAS 1508-65-2] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P73335-10ug
|
MedChemexpress LLC
|
p38 Alpha/MAPK14, Human (Activated, sf9, His)
|
|
|
|
|
HY-P73335-5ug
|
MedChemexpress LLC
|
p38 Alpha/MAPK14, Human (Activated, sf9, His)
|
|
|
|
|
HY-P73335-50ug
|
MedChemexpress LLC
|
p38 Alpha/MAPK14, Human (Activated, sf9, His)
|
|
|
|
